BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 8641337)

  • 1. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages.
    Sutherland JA; Turner AR; Mannoni P; McGann LE; Turc JM
    J Biol Response Mod; 1986 Jun; 5(3):250-62. PubMed ID: 2425057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.
    Rowley PT; Farley BA; LaBella S; Giuliano R; Leary JF
    Int J Cell Cloning; 1992 Jul; 10(4):232-40. PubMed ID: 1645031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced myeloid differentiation of K562 cells with downregulation of erythroid and megakaryocytic transcription factors: a novel experimental model for hemopoietic lineage restriction.
    Green AR; Rockman S; DeLuca E; Begley CG
    Exp Hematol; 1993 Apr; 21(4):525-31. PubMed ID: 8462662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of H-related antigen on human megakaryocytes and megakaryocytic leukemia cells.
    Okumura M; Morishima Y; Ogura M; Morishita Y; Tanimoto M; Ohno R; Saito H
    Int J Hematol; 1991 Apr; 54(2):151-8. PubMed ID: 1747448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
    Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
    Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of multiple hematopoietic-cell lineages in multiple myeloma.
    Epstein J; Xiao HQ; He XY
    N Engl J Med; 1990 Mar; 322(10):664-8. PubMed ID: 2137556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
    Yen A; Varvayanis S; Platko JD
    Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
    Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
    Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-x is a regulatory factor of apoptosis and differentiation in megakaryocytic lineage cells.
    Terui Y; Furukawa Y; Kikuchi J; Iwase S; Hatake K; Miura Y
    Exp Hematol; 1998 Mar; 26(3):236-44. PubMed ID: 9502620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages.
    Martin DI; Zon LI; Mutter G; Orkin SH
    Nature; 1990 Mar; 344(6265):444-7. PubMed ID: 2320112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line.
    Majumdar A; Kerby S; Stenberg PE; Mullikin B; Beckstead JH; Cooney DA; Seidman MM
    J Cell Physiol; 1994 Jul; 160(1):29-39. PubMed ID: 8021297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics.
    Seigneurin D; Champelovier P; Mouchiroud G; Berthier R; Leroux D; Prenant M; McGregor J; Starck J; Morle F; Micouin C
    Exp Hematol; 1987 Sep; 15(8):822-32. PubMed ID: 3476310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and differentiation of two human megakaryoblastic cell lines; CMK and UT-7.
    Miura Y; Komatsu N; Suda T
    Prog Clin Biol Res; 1990; 356():259-70. PubMed ID: 2217443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of smg p21/rap1A p21/krev-1 p21 gene expression during phorbol ester-induced differentiation of a human megakaryocytic leukemia cell line.
    Adachi M; Ryo R; Yoshida A; Sugano W; Yasunaga M; Saigo K; Yamaguchi N; Sato T; Sano K; Kaibuchi K
    Oncogene; 1992 Feb; 7(2):323-9. PubMed ID: 1549353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines.
    Navarro S; Mitjavila MT; Katz A; Doly J; Vainchenker W
    Exp Hematol; 1991 Jan; 19(1):11-7. PubMed ID: 1989890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation.
    Tenailleau S; Corre I; Hermouet S
    Exp Hematol; 1997 Aug; 25(9):927-34. PubMed ID: 9257805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin.
    Vannucchi AM; Grossi A; Paoletti F; Rafanelli D; Bacci P; Ferrini PR
    Exp Hematol; 1992 Dec; 20(11):1296-301. PubMed ID: 1493858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.